These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35939969)

  • 21. Non Pharmaceutical Interventions for Optimal Control of COVID-19.
    Zamir M; Shah Z; Nadeem F; Memood A; Alrabaiah H; Kumam P
    Comput Methods Programs Biomed; 2020 Nov; 196():105642. PubMed ID: 32688137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SARS-CoV-2 Pandemic in High Income Countries Such as Canada: A Better Way Forward Without Lockdowns.
    Joffe AR; Redman D
    Front Public Health; 2021; 9():715904. PubMed ID: 34926364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.
    Ngonghala CN; Iboi E; Eikenberry S; Scotch M; MacIntyre CR; Bonds MH; Gumel AB
    Math Biosci; 2020 Jul; 325():108364. PubMed ID: 32360770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of within-host genetic diversity in SARS-CoV-2.
    Tonkin-Hill G; Martincorena I; Amato R; Lawson ARJ; Gerstung M; Johnston I; Jackson DK; Park N; Lensing SV; Quail MA; Gonçalves S; Ariani C; Spencer Chapman M; Hamilton WL; Meredith LW; Hall G; Jahun AS; Chaudhry Y; Hosmillo M; Pinckert ML; Georgana I; Yakovleva A; Caller LG; Caddy SL; Feltwell T; Khokhar FA; Houldcroft CJ; Curran MD; Parmar S; ; Alderton A; Nelson R; Harrison EM; Sillitoe J; Bentley SD; Barrett JC; Torok ME; Goodfellow IG; Langford C; Kwiatkowski D;
    Elife; 2021 Aug; 10():. PubMed ID: 34387545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High variability in transmission of SARS-CoV-2 within households and implications for control.
    Toth DJA; Beams AB; Keegan LT; Zhang Y; Greene T; Orleans B; Seegert N; Looney A; Alder SC; Samore MH
    PLoS One; 2021; 16(11):e0259097. PubMed ID: 34758042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done.
    Luo R; Delaunay-Moisan A; Timmis K; Danchin A
    Environ Microbiol; 2021 May; 23(5):2339-2363. PubMed ID: 33769683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public health actions to control new SARS-CoV-2 variants.
    Grubaugh ND; Hodcroft EB; Fauver JR; Phelan AL; Cevik M
    Cell; 2021 Mar; 184(5):1127-1132. PubMed ID: 33581746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
    Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
    Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA.
    Lau MSY; Grenfell B; Thomas M; Bryan M; Nelson K; Lopman B
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22430-22435. PubMed ID: 32820074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.
    Liu Y; Morgenstern C; Kelly J; Lowe R; ; Jit M
    BMC Med; 2021 Feb; 19(1):40. PubMed ID: 33541353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leveraging epidemiological principles to evaluate Sweden's COVID-19 response.
    Baral S; Chandler R; Prieto RG; Gupta S; Mishra S; Kulldorff M
    Ann Epidemiol; 2021 Feb; 54():21-26. PubMed ID: 33242596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study.
    Rader B; White LF; Burns MR; Chen J; Brilliant J; Cohen J; Shaman J; Brilliant L; Kraemer MUG; Hawkins JB; Scarpino SV; Astley CM; Brownstein JS
    Lancet Digit Health; 2021 Mar; 3(3):e148-e157. PubMed ID: 33483277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lockdown Efficacy in Controlling the Spread of COVID-19 May Be Waning Due to Decline in Public Compliance, Especially among Unvaccinated Individuals: A Cross-Sectional Study in Israel.
    Bodas M; Adini B; Jaffe E; Kaim A; Peleg K
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [SARS-CoV-2 transmission routes and implications for self- and non-self-protection].
    Oh DY; Böttcher S; Kröger S; von Kleist M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Sep; 64(9):1050-1057. PubMed ID: 34324023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2.
    Huisman JS; Scire J; Angst DC; Li J; Neher RA; Maathuis MH; Bonhoeffer S; Stadler T
    Elife; 2022 Aug; 11():. PubMed ID: 35938911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptions of Covid-19 lockdowns and related public health measures in Austria: a longitudinal online survey.
    Łaszewska A; Helter T; Simon J
    BMC Public Health; 2021 Aug; 21(1):1502. PubMed ID: 34344343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Associated with the Implementation of Non-Pharmaceutical Interventions for Reducing Coronavirus Disease 2019 (COVID-19): A Systematic Review.
    Regmi K; Lwin CM
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superspreading of SARS-CoV-2 in the USA.
    Pozderac C; Skinner B
    PLoS One; 2021; 16(3):e0248808. PubMed ID: 33765004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.
    Talic S; Shah S; Wild H; Gasevic D; Maharaj A; Ademi Z; Li X; Xu W; Mesa-Eguiagaray I; Rostron J; Theodoratou E; Zhang X; Motee A; Liew D; Ilic D
    BMJ; 2021 Nov; 375():e068302. PubMed ID: 34789505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating the effect of non-pharmaceutical interventions to mitigate COVID-19 spread in Saudi Arabia.
    Bisanzio D; Reithinger R; Alqunaibet A; Almudarra S; Alsukait RF; Dong D; Zhang Y; El-Saharty S; Herbst CH
    BMC Med; 2022 Feb; 20(1):51. PubMed ID: 35125108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.